BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38280862)

  • 1. AKT2
    Chen J; Zhang L; Zhu Y; Zhao D; Zhang J; Zhu Y; Pang J; Xiao Y; Wu Q; Wang Y; Zhan Q
    Signal Transduct Target Ther; 2024 Jan; 9(1):21. PubMed ID: 38280862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network.
    Zhang L; Zhao D; Wang Y; Zhang W; Zhang J; Fan J; Zhan Q; Chen J
    Mol Carcinog; 2021 Feb; 60(2):113-124. PubMed ID: 33283357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
    Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
    Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
    Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
    Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose Drives Growth Factor-Independent Esophageal Cancer Proliferation via Phosphohistidine-Focal Adhesion Kinase Signaling.
    Zhang J; Gelman IH; Katsuta E; Liang Y; Wang X; Li J; Qu J; Yan L; Takabe K; Hochwald SN
    Cell Mol Gastroenterol Hepatol; 2019; 8(1):37-60. PubMed ID: 30836148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC).
    Chen J; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q
    Cell Mol Immunol; 2022 Sep; 19(9):1054-1066. PubMed ID: 35962191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOX5 mediates the crosstalk between tumor cells and cancer-associated fibroblasts via regulating cytokine network.
    Chen J; Wang Y; Zhang W; Zhao D; Zhang L; Zhang J; Fan J; Zhan Q
    Clin Transl Med; 2021 Aug; 11(8):e472. PubMed ID: 34459125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
    Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
    Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
    Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
    Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma.
    Zhao G; Li H; Guo Q; Zhou A; Wang X; Li P; Zhang S
    Cancer Med; 2020 Apr; 9(7):2500-2513. PubMed ID: 32030915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma.
    Liu B; Zhang B; Qi J; Zhou H; Tan L; Huang J; Huang J; Fang X; Gong L; Luo J; Liu S; Fu L; Ling F; Ma S; Lai-Wan Kwong D; Wang X; Guan XY
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2307914120. PubMed ID: 37816055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diacylglycerol kinase α (DGKα)/Akt/NF-κB feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner.
    Chen J; Zhang W; Wang Y; Zhao D; Wu M; Fan J; Li J; Gong Y; Dan N; Yang D; Liu R; Zhan Q
    Oncogene; 2019 Apr; 38(14):2533-2550. PubMed ID: 30532074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
    Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
    Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma.
    Shin WS; Kwon J; Lee HW; Kang MC; Na HW; Lee ST; Park JH
    Cancer Sci; 2013 Aug; 104(8):1120-6. PubMed ID: 23663482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
    Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
    Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma.
    Dunbar KJ; Karakasheva TA; Tang Q; Efe G; Lin EW; Harris M; Sahu V; Sachdeva UM; Hu J; Klein-Szanto AJ; Henick B; Diehl JA; Nakagawa H; Rustgi AK
    Mol Cancer Res; 2023 Jul; 21(7):741-752. PubMed ID: 37027010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.
    Che Y; Wang J; Li Y; Lu Z; Huang J; Sun S; Mao S; Lei Y; Zang R; Sun N; He J
    Cell Death Dis; 2018 Jul; 9(7):759. PubMed ID: 29988148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
    Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
    Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
    Luo QY; Zhou SN; Pan WT; Sun J; Yang LQ; Zhang L; Qiu MZ; Yang DJ
    Biochem Pharmacol; 2021 Jan; 183():114318. PubMed ID: 33159967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
    Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
    J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.